PALB2 mutations and breast-cancer risk.
作者信息
Evans Michele K, Longo Dan L
机构信息
From the Health Disparities Research Section, Laboratory of Epidemiology and Populations Sciences, National Institute on Aging, National Institutes of Health, Baltimore (M.K.E.).
出版信息
N Engl J Med. 2014 Aug 7;371(6):566-8. doi: 10.1056/NEJMe1405784.
Abstract
摘要
相似文献
1
PALB2 mutations and breast-cancer risk.
N Engl J Med. 2014 Aug 7;371(6):566-8. doi: 10.1056/NEJMe1405784.
2
Breast-cancer risk in families with mutations in PALB2.
N Engl J Med. 2014 Aug 7;371(6):497-506. doi: 10.1056/NEJMoa1400382.
3
Breast-cancer risk in families with mutations in PALB2.
N Engl J Med. 2014 Oct 23;371(17):1650-1. doi: 10.1056/NEJMc1410673.
4
Breast-cancer risk in families with mutations in PALB2.
N Engl J Med. 2014 Oct 23;371(17):1650. doi: 10.1056/NEJMc1410673#SA1.
5
Breast-cancer risk in families with mutations in PALB2.
N Engl J Med. 2014 Oct 23;371(17):1651-2. doi: 10.1056/NEJMc1410673.
6
Breast cancer: PALB2--a new player in hereditary breast cancer.
Nat Rev Clin Oncol. 2014 Oct;11(10):560. doi: 10.1038/nrclinonc.2014.142. Epub 2014 Aug 19.
7
A PALB2 germline mutation associated with hereditary breast cancer in Italy.
Fam Cancer. 2010 Jun;9(2):181-5. doi: 10.1007/s10689-009-9295-z. Epub 2009 Sep 18.
8
Biallelic mutations in PALB2 cause Fanconi anemia subtype FA-N and predispose to childhood cancer.
Nat Genet. 2007 Feb;39(2):162-4. doi: 10.1038/ng1947. Epub 2006 Dec 31.
9
PALB2, which encodes a BRCA2-interacting protein, is a breast cancer susceptibility gene.
Nat Genet. 2007 Feb;39(2):165-7. doi: 10.1038/ng1959. Epub 2006 Dec 31.
10
Screening for BRCA1, BRCA2, CHEK2, PALB2, BRIP1, RAD50, and CDH1 mutations in high-risk Finnish BRCA1/2-founder mutation-negative breast and/or ovarian cancer individuals.
Breast Cancer Res. 2011 Feb 28;13(1):R20. doi: 10.1186/bcr2832.
引用本文的文献
1
Impact of Early Testing and Analysis of Germline Genetic Mutation in Patients with Breast Cancer: A Single Institution Experience.
J Cancer Prev. 2025 Mar 30;30(1):41-46. doi: 10.15430/JCP.25.001.
2
Association between single nucleotide polymorphisms of DNA repair genes (BRCA1, BRCA2, and PALB2) and breast cancer incidence in a subset of Iranian population.
Hered Cancer Clin Pract. 2025 Mar 29;23(1):12. doi: 10.1186/s13053-025-00311-0.
3
Hodgkin lymphoma and Ewing sarcoma in pediatric patient carrying germline variant: a case report and literature review.
Front Oncol. 2025 Feb 18;15:1514697. doi: 10.3389/fonc.2025.1514697. eCollection 2025.
4
Key molecular DNA damage responses of human cells to radiation.
Front Cell Dev Biol. 2024 Jul 10;12:1422520. doi: 10.3389/fcell.2024.1422520. eCollection 2024.
5
Clinico-genomic findings, molecular docking, and mutational spectrum in an understudied population with breast cancer patients from KP, Pakistan.
Front Genet. 2024 May 9;15:1383284. doi: 10.3389/fgene.2024.1383284. eCollection 2024.
6
The frequency of pathogenic variation in the All of Us cohort reveals ancestry-driven disparities.
Commun Biol. 2024 Feb 19;7(1):174. doi: 10.1038/s42003-023-05708-y.
7
Oncoplastic and reconstructive breast surgery.
Front Oncol. 2023 Jun 28;13:1176915. doi: 10.3389/fonc.2023.1176915. eCollection 2023.
8
DNA Repair Mechanisms, Protein Interactions and Therapeutic Targeting of the MRN Complex.
Cancers (Basel). 2022 Oct 27;14(21):5278. doi: 10.3390/cancers14215278.
9
Mutational Characterization of Colorectal Cancer from Korean Patients with Targeted Sequencing.
J Cancer. 2021 Oct 28;12(24):7300-7310. doi: 10.7150/jca.61324. eCollection 2021.
10
variants of uncertain significance in clinical practice: A case report.
Mol Clin Oncol. 2021 Nov;15(5):222. doi: 10.3892/mco.2021.2385. Epub 2021 Aug 31.
本文引用的文献
1
Breast-cancer risk in families with mutations in PALB2.
N Engl J Med. 2014 Aug 7;371(6):497-506. doi: 10.1056/NEJMoa1400382.
2
Identifying and exploiting defects in the Fanconi anemia/BRCA pathway in oncology.
Transl Res. 2012 Sep;160(3):178-97. doi: 10.1016/j.trsl.2012.01.022. Epub 2012 Feb 9.
3
BRCA1 and BRCA2: different roles in a common pathway of genome protection.
Nat Rev Cancer. 2011 Dec 23;12(1):68-78. doi: 10.1038/nrc3181.
4
Novel germline PALB2 truncating mutations in African American breast cancer patients.
Cancer. 2012 Mar 1;118(5):1362-70. doi: 10.1002/cncr.26388. Epub 2011 Aug 26.
5
Contribution of inherited mutations in the BRCA2-interacting protein PALB2 to familial breast cancer.
Cancer Res. 2011 Mar 15;71(6):2222-9. doi: 10.1158/0008-5472.CAN-10-3958. Epub 2011 Feb 1.
6
Germline mutations in PALB2 in African-American breast cancer cases.
Breast Cancer Res Treat. 2011 Feb;126(1):227-30. doi: 10.1007/s10549-010-1271-7. Epub 2010 Nov 27.
7
PALB2/FANCN: recombining cancer and Fanconi anemia.
Cancer Res. 2010 Oct 1;70(19):7353-9. doi: 10.1158/0008-5472.CAN-10-1012. Epub 2010 Sep 21.
8
Deficiency in the repair of DNA damage by homologous recombination and sensitivity to poly(ADP-ribose) polymerase inhibition.
Cancer Res. 2006 Aug 15;66(16):8109-15. doi: 10.1158/0008-5472.CAN-06-0140.
9
Targeting the DNA repair defect in BRCA mutant cells as a therapeutic strategy.
Nature. 2005 Apr 14;434(7035):917-21. doi: 10.1038/nature03445.
Zotero 插件